Emilie Gauthy, PhD Celyad

Emilie Gauthy is a Bioengineer by training. She earned her PhD in 2013 at the De Duve Institute in Brussels where she focused on cancer immunology and specifically on the modulation of regulatory T cells function by micro-RNAs.

Since then, she had diverse experiences in the pharmaceutical industry covering roles such as QC scientist, QA supervisor at GlaxoSmithKline’s Industrialization department for the development of new vaccines and CMC project manager for oncological sterile product manufacturing in a CDMO.

She joined Celyad Oncology in 2018 within the Industrialization team to oversee CMOs & CROs work and act as the Raw and Starting Materials Site Matter Expert. She is currently leading a scientific team dedicated to the development and validation of next generation allogeneic CAR-T products, bringing product candidates from research to clinical manufacturing.